Kevin M. Farr - Aug 12, 2022 Form 4 Insider Report for ChromaDex Corp. (CDXC)

Role
CHIEF FINANCIAL OFFICER
Signature
/s/ Jeong James Lee, Attorney-in-Fact
Stock symbol
CDXC
Transactions as of
Aug 12, 2022
Transactions value $
$0
Form type
4
Date filed
8/12/2022, 09:09 PM
Previous filing
Jul 5, 2022
Next filing
Oct 5, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CDXC Restricted Stock Unit Award $0 +89.2K $0.00 89.2K Aug 12, 2022 Common Stock 89.2K Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Kevin M. Farr is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 On August 12, 2022, the Reporting Person was awarded Restricted Stock Units ("RSUs") in connection with the Reporting Person's transition services to the Issuer and the related consulting agreement with the Reporting Person (the "Consultant Agreement") effective August 13, 2022. The reporting person was terminated as the Chief Financial Officer of the Issuer effective August 12, 2022.
F2 RSUs shall vest and be settled in shares of Common Stock upon the earlier of the expiration of the Consultant Agreement, which is expected to be on or around November 11, 2022, or the earlier termination of the Consultant Agreement.